|
The FDA wanted Duloxetine to carry a black box warning stating that
antidepressants may increase the risk of suicide in youngsters. This
warning is based on clinical trials conducted by two independent
groups of the FDA experts. According to the Food and Drug
Association of United States (US) Duloxetine was provided for
majority of the diseases. Four completed suicides occurred in the
trials of Duloxetine for stress urinary incontinence.
FDA initially insisted that any information about them is a
commercial secret and cannot be released. The manufacturer Eli Lilly
said the FDA has approved Cymbalta for the treatment of GAD in
February 2007. Eli Lilly and Company announced submission of a
supplement to FDA for the treatment of generalized anxiety disorder.
FDA has specifically asked to label the half life period, mg
content, usage of the Duloxetine pills. Duloxetine is also used to
treat nerve pain in the feet, legs, or hands due to nerve damage
caused by poorly controlled diabetes.
Duloxetine drug enhance the nerve signals within the central nervous
system inhibiting pain. FDA found out Duloxetine is not effective
for the complications of diabetes. The drug was only saled by Eli
Lilly and Company using the brand name Cymbalta. FDA report
specifies the treatment for various diseases are providing with
Duloxetine. The approval of these pills by the FDA was not on mere
notices. Thus the treatment with Cymbalta in the near future can be
considered as the best.
|
